
Bonesupport Holding AB (publ) (2B4.F)
ValueMarkers Composite Index
DCF data not available
Bonesupport Holding AB (publ) (2B4.F) — VMCI valuation read
2B4.F prints VMCI 62/100 inside the Healthcare sector, where the median sits at 50. The 12-point above-median delta is the cleanest single-number summary of Bonesupport Holding AB (publ)'s composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On 2B4.F, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** 2B4.F trades at 26.0x earnings, 44% above the Healthcare median of 18.0x; that is the value line. ROIC of 10.0% sits 0.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 2.1x is the rate-sensitivity line to watch; that is the risk line for Bonesupport Holding AB (publ) on the trailing financials.
2B4.F rose 1.2% over the trailing 7 days, with a -8.1% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- BOEUF - Bonesupport Holding AB (publ)
- BITGF - Biotage AB (publ)
- BOEUF - Bonesupport Holding AB (publ)
- 3886.HK - Town Health International Medical Group Limited
- 476060.KQ - Onconic Therapeutics
- TAK - Takeda Pharmaceutical Company Limited
- TKPHF - Takeda Pharmaceutical Company Limited
- LFTSF - LifeTech Scientific Corporation